Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional
Official Title: A Randomized, Open-label Study of Ponatinib Versus Nilotinib in Patients With Chronic Myeloid Leukemia in Chronic Phase Following Resistance to Imatinib
Brief Summary: The purpose of this study is to compare the efficacy and safety of 2 starting doses of ponatinib compared to nilotinib in patients with imatinib-resistant chronic myeloid leukemia (CML) in chronic phase (CP).